MedPath

ENSPRYNG 120 mg SOLUCION INYECTABLE EN JERINGA PRECARGADA

ENSPRYNG 120 mg SOLUCION INYECTABLE EN JERINGA PRECARGADA

Commercialized
Register Number

1211559001

Prescription Type

Diagnóstico Hospitalario

Authorization Date

Jul 26, 2021

Dosage Form

SOLUCIÓN INYECTABLE EN JERINGA PRECARGADA

Route: VÍA SUBCUTÁNEA

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number1211559001
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
Yes
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

SATRALIZUMABActive
Quantity: 120 mg
Name: SATRALIZUMAB

ATC CLASSIFICATION (3)

L04A
L04AC
L04AC19

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.